PAX8-PPAR γ and RAS mutations tend to correlate with specific phenotypical features of follicular carcinomas. Targeted therapy for thyroid cancer with BRAF and RET inhibitors has progressed to ...

Fibrates are widely prescribed agonists of transcription factor peroxisome proliferator-activated receptor (PPAR)-α, and are used to treat patients with atherogenic dyslipidemia. These drugs ...